| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/22/2002 | WO2002004412A3 Tyrosine derivatives as phosphatase inhibitors |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2000033865A9 Methods of inhibiting ectopic calcification |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115727 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines |
| 08/22/2002 | US20020115726 Methods and compositions for treating depression and other disorders using optically pure (-) -bupropion |
| 08/22/2002 | US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 08/22/2002 | US20020115712 Highly purified simvastatin compositions |
| 08/22/2002 | US20020115709 Atorvastatin hemi-calcium form VII |
| 08/22/2002 | US20020115684 2, 7-naphthyridine derivatives |
| 08/22/2002 | US20020115676 Therapy for andropause using estrogen agonists / antagonists and testosterone |
| 08/22/2002 | US20020115667 Treatment of disorders associated with glycolipid accumulation, such as Niemann-Pick Type C disease by administering an inhibitor of glucosylceramide synthesis, such as N-butyldeoxynojirimycin |
| 08/22/2002 | US20020115654 New compounds, their preparation and use |
| 08/22/2002 | US20020115635 Modulation of GSK-3beta activity and its different uses |
| 08/22/2002 | US20020115627 Phosphatonin-related gene and methods of use thereof |
| 08/22/2002 | US20020115616 Inhibit beta-secretase to reduce beta amyloid peptide concentrations and reduce the amyloid plaques and neuro-fibrillary tangles; Alzheimer's disease; stroke; Down' syndrome; amyotrophic lateral sclerosis; brain disorders |
| 08/22/2002 | US20020115592 And optionally aprotinin, in a nonaqueous hydrophilic medium of an alcohol and a cosolvent, in association with a medium chain partial glyceride, optionally in admixture a long-chain polyoxyethylene glycol; fine suspension |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115102 Novel protein |
| 08/22/2002 | US20020114839 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | DE10108212A1 Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände Fusion protein for secretion of value protein in bacterial supernatants |
| 08/22/2002 | DE10100238A1 Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests A method for predicting the risk potential for cancer diseases and inflammatory bowel disease and related tests |
| 08/22/2002 | DE10055857A1 Neue pharmazeutische Depotformulierung New pharmaceutical depot formulation |
| 08/22/2002 | CA2856986A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2666611A1 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | CA2438712A1 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | CA2438551A1 Ppar agonists |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438492A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | CA2436713A1 Proteins and nucleic acids encoding same |
| 08/22/2002 | CA2436195A1 Laulimalide derivatives |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/22/2002 | CA2401383A1 Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use |
| 08/21/2002 | EP1233063A2 Transgenic animals containing a dominant negative mutant form of the p85 subunit of pi-3 kinase |
| 08/21/2002 | EP1233021A2 An inhibitor of Beta amyloid cleavage enzyme |
| 08/21/2002 | EP1233015A1 Use of imidazole derivatives for the treatement of deseases involving the AT1 and AT2s receptors of angiotensine, some of these products, their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 08/21/2002 | EP1233013A1 Novel phenylalanine derivatives |
| 08/21/2002 | EP1232757A1 Remedies for diseases in association with decrease in bone mass |
| 08/21/2002 | EP1232751A1 Remedies for periodontosis |
| 08/21/2002 | EP1232750A1 Non-beta-oxidizable fatty acid analogues and their use for reduction of growth of cancer cells |
| 08/21/2002 | EP1232749A1 Non-beta-oxidizable fatty acid analogues and their uses for inhibition of oxidative modification of low density lipoprotein |
| 08/21/2002 | EP1232266A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232247A2 Modulation of signal transduction |
| 08/21/2002 | EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 08/21/2002 | EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1231937A2 Tr3-specific binding agents and methods for their use |
| 08/21/2002 | EP1231923A1 Protease inhibitors |
| 08/21/2002 | EP1231922A1 Protease inhibitors |
| 08/21/2002 | EP1231918A2 Novel composition based on a thiazolidinedione and metformin and use |
| 08/21/2002 | EP1231917A2 Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride |
| 08/21/2002 | EP1231916A2 Use of indirubine derivatives for making medicines |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP1231907A2 Dextrose and insulin fluid formulation for intravenous infusion |
| 08/21/2002 | EP1231904A2 A method of microencapsulation |
| 08/21/2002 | EP1231887A2 Method and composition for the treatment of scars |
| 08/21/2002 | EP1154801A4 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 08/21/2002 | EP0756596B1 Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors |
| 08/21/2002 | EP0696194B1 Use of indole derivatives as 5ht1 antagonists |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1365361A Fused imiazole compounds and remedies for diabetes mellitus |
| 08/21/2002 | CN1365359A Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 08/21/2002 | CN1365354A Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 08/21/2002 | CN1365287A Pharmaceutical composition containing enantioners and lipase inhibitor |
| 08/21/2002 | CN1365285A Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvia area |
| 08/21/2002 | CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 08/21/2002 | CN1365283A Unfermented gel fraction from psyllium seed husks |
| 08/21/2002 | CN1365279A Preparations for reducing oxygen consumption during physical efforts |
| 08/21/2002 | CN1365276A Method for treating eating disorders |
| 08/21/2002 | CN1364632A Chinese patent medicine for curing diabetes |
| 08/21/2002 | CN1364624A Specific medicine for curing diabetes |
| 08/21/2002 | CN1364610A Blood sugar reducing tea |
| 08/21/2002 | CN1364548A Nano Kanghong medicine and its preparing method |
| 08/21/2002 | CN1364512A Defatting and poison expelling capsule |
| 08/21/2002 | CN1089238C Method for lowering cholesterol |
| 08/21/2002 | CN1089236C Medicinal composition for preventing and curing hypokalemia |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437143 Thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 08/20/2002 | US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 08/20/2002 | US6436977 Dosing regimens for lasofoxifene |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436957 Indole derivatives as 5-HT1 agonists |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436899 Nutritional intervention composition for enhancing and extending satiety |
| 08/20/2002 | US6436704 Cell differentiation into acinar, ductal, and islet cells; immunogens; bioassays |
| 08/20/2002 | US6436684 Isolated nucleic acid molecule consisting of selected nucleotide sequence encoding phenol sulfotransferase protein |
| 08/20/2002 | US6436670 Gene and uses therefor |